Insider Stock Trading History of Clayman Michael D.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clayman Michael D. since year 2005. The trader's CIK number is 1597407. At the time of this reporting, Clayman Michael D. is the President and CEO of Flexion Therapeutics Inc . (stock ticker symbol FLXN). See this page for all insider trading activities at Flexion Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Clayman Michael D. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-08 FLXN Flexion Therapeutics Inc Buy 5,000 23.60 118,000
2017-10-06 FLXN Flexion Therapeutics Inc Option Ex 14,800 .00 0
2017-06-05 FLXN Flexion Therapeutics Inc Buy 5,000 17.23 86,150
2016-11-23 FLXN Flexion Therapeutics Inc Buy 1,667 18.41 30,687
2016-11-22 FLXN Flexion Therapeutics Inc Buy 1,666 17.95 29,899
2016-11-21 FLXN Flexion Therapeutics Inc Buy 1,666 17.90 29,828
2016-05-23 FLXN Flexion Therapeutics Inc Option Ex 10,369 .16 1,690
2016-05-20 FLXN Flexion Therapeutics Inc Buy 2,000 10.40 20,810
2016-05-19 FLXN Flexion Therapeutics Inc Buy 2,000 9.65 19,298
2016-05-18 FLXN Flexion Therapeutics Inc Buy 2,000 10.23 20,466
2016-05-17 FLXN Flexion Therapeutics Inc Buy 2,000 9.73 19,466
2016-05-16 FLXN Flexion Therapeutics Inc Buy 2,000 9.51 19,026
2015-03-24 FLXN Flexion Therapeutics Inc Option Ex 5,000 .16 815

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clayman Michael D. (President and CEO of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.